J.P. Klussmann
Papers
1
Total Citations
2
H-Index
1
About
J.P. Klussmann is a leading surgical oncologist whose research focuses on optimizing treatment strategies for head and neck cancers, particularly oropharyngeal, supraglottic, and hypopharyngeal carcinomas. His major contribution lies in pioneering comparative effectiveness studies that directly evaluate radiotherapy versus trans-oral surgery (TOS) for early-stage tumors. The landmark 2022 Phase III trial (706TiP) he authored, which has garnered 2 citations, is a critical step toward establishing evidence-based guidelines for T1-T2, N0-N1 oropharyngeal and supraglottic cancers, as well as T1 hypopharyngeal carcinomas. This work addresses a long-standing clinical debate by systematically comparing the "best of" radiotherapy against the "best of" surgery, aiming to define optimal, patient-specific treatment pathways. Klussmann’s research is instrumental in advancing minimally invasive surgical techniques and personalized oncology, offering clearer prognostic and quality-of-life outcomes for patients. His dedication to rigorous clinical trials underscores his impact on head and neck cancer management, making him a key figure in shaping contemporary therapeutic approaches.
Research Focus
Key Achievements
Top Papers
- 1